Table 3.
Clinical variable | Gene | Gene expression valuea | Toxicity grade | Adjusted p-value | RT timing |
---|---|---|---|---|---|
Dermatitis radiation | FDXR | 1.44 | G2 | 0.096c | t1 |
1.88 | G3 | ||||
Pain | SESN1 | 1.36 | G0 | 0.043b | t1 |
0.97 | G1 | ||||
SESN1 | 1.36 | Absent | 0.020b | t1 | |
0.92 | Present | ||||
Pruritus | XPC | 1.49 | G1 | 0.102c | t1 |
0.79 | G2 | ||||
ZMAT3 | 1.43 | G0 | 0.046b | t1 | |
1.01 | G1 | ||||
ATM | 1.29 | Absent | 0.021b | t2 | |
0.87 | Present | ||||
BCL2/BAX | 1.15 | Absent | 0.011b | t2 | |
0.76 | Present | ||||
Fatigue | CDKN1A | 1.42 | G0 | 0.049b | t2 |
1.19 | G1 |
Gene expression values are reported in irradiated relative to non-irradiated blood samples from RT patients and expressed in fold-change.
t-test;
Wilcoxon test. Bonferroni adjusted p-value is significant when <0.05, moderately significant when <0.10.